{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Showing 1 - 6 of 6 results
Status:
US Previously Marketed
Source:
MILIBIS GLYCOBIARSOL by WINTHROP
(1961)
Source URL:
First approved in 1949
Class (Stereo):
CHEMICAL (ACHIRAL)
Conditions:
Glycobiarsol was known under the brand name Milibis. Glycobiarsol is found to be very effective in intestinal infections. Milibis is an antiprotozoal agent that has been used in humans as well as in dogs.
Status:
Possibly Marketed Outside US
Source:
Buterazine by Daiichi Seiyaku
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Conditions:
Budralazine is a vasodilator. Budralazine is a direct-acting vasodilating agent that does not produce marked tachycardia. Hypotensive effect of Buterazine has being shown. Budralazine is reported as an ingredient of Buterazine in Japan.
Status:
Possibly Marketed Outside US
Class (Stereo):
CHEMICAL (RACEMIC)
Conditions:
Octamylamine is an Antispasmodic. Trademark: Octinum D.
Status:
Possibly Marketed Outside US
Class (Stereo):
CHEMICAL (MIXED)
Conditions:
Octamylamine is an Antispasmodic. Trademark: Octinum D.
Status:
Possibly Marketed Outside US
Class (Stereo):
CHEMICAL (RACEMIC)
Conditions:
Octamylamine is an Antispasmodic. Trademark: Octinum D.
Status:
Possibly Marketed Outside US
Class (Stereo):
CHEMICAL (RACEMIC)
Conditions:
Octamylamine is an Antispasmodic. Trademark: Octinum D.
